logo
Study calls for more research into effects of opioids during pregnancy

Study calls for more research into effects of opioids during pregnancy

Based on the results of her and her team's most recent study, she said there is an 'urgent need for greater knowledge of how exposure to substances such as fentanyl, heroin, and a multitude of prescription painkillers in the womb impacts the health and development of children.'
Dr Marryat said studies suggest roughly 1 in 100 children in Scotland are affected by opioid use in pregnancy. That is approximately the same rate as the Scottish children who have autism, according to NHS data.
Crucially, however, there is a lack of scientific research into children who were exposed to opioids in the womb. As a result, little is known about the direct links between specific cognitive and physical symptoms in early childhood and exposure.
Dr Marryat has said that better studies of children's environments and development can provide clearer answers, helping to make medicine more efficient and supporting children during their development.
However, she said more information is needed to do that, and this means better access to and understanding of vulnerable children and families.
'We need to provide healthcare providers, government, and parents with the information that is needed to ensure that countless numbers of children receive the information and support they deserve.'
Dy Marryat and the Dundee team's study analysed 478 papers dealing with exposure to opioids in the womb and resulting childhood impacts. As an umbrella study, the goal was to combine existing data to identify potential links between opioid use during pregnancy and developmental difficulties in children.
Dr Louise Marryat, an expert in infant health at the University's School of Health Sciences has suggested that battling the stigma around opioid use could lead to better medical care for affected children. (Image: Creative Services EJA)
The team found potential links to specific physical impairments in visual development and motor skills, and also that children exposed to opioids in the womb were at increased risk of behavioural problems and language difficulties.
But Dr Marryat said the fundamental importance of her team's findings may be in the gaps they uncovered. The umbrella study focused on children from birth until preschool age.
In the report's findings, the team argued that longer-term studies of affected children are the only reliable evidence for informing medical practice and government policy.
Read more
Without larger sample sizes and access to children as they continue to develop later in their lives, she said, it can be impossible to know for sure whether the linked difficulties are a direct result of opioid exposure or a combination of other complex environmental factors.
"If you're having behavioural difficulties with children, we do not know if that's because they have been exposed to opioids in pregnancy which has made changes in the way their brain has developed, or whether it is because of the environment that they are living in and what has happened to them since birth.
'It might be in part that it's just a bit too early to measure some of these signs.'
Closing these gaps can mean better protection for pregnant mothers and their children and better interventions for exposed children later in life. One reason more research on the effects of opioids during pregnancy can prove beneficial is that a majority of mothers who use these substances while pregnant are using prescription drugs, such as methadone.
She said a better understanding of the long-term impacts can allow healthcare providers to make better-informed decisions about how to support pregnant mothers.
'Women who use opioids in pregnancy overwhelmingly want the best for their child. During pregnancy, the focus for mothers is very much on having a healthy baby. These are fundamental and understandable concerns but focus less on the long-term outcomes of the child, even when exposed to opioids.'
However, Dr Maryatt said that researchers and healthcare providers need families to feel comfortable coming forward and engaging with the system in order to close these gaps.
However, she said this brings its own challenges.
"I think we have really good universal services. We have a really strong tradition of health visiting, but I think it's really under-resourced.
'For these families impacted by opioid use, it can be particularly tricky to engage in services. First, because they are often stigmatised by the services that are meant to help them, and the parents who have used drugs have experienced lots of stigma.
'Many fear that their children may be removed from their care. There needs to be appropriate pathways providing services that work alongside parents to fully support children and families in challenges they might face, but that is not easy when many services are already stretched.
'We need to be in a position to give people the information that they need to make decisions for themselves, to make informed decisions, but also to make sure that we do not increase the stigma as well around substance use.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NHS urges Tesco shoppers to read important life saving labels in store
NHS urges Tesco shoppers to read important life saving labels in store

Daily Record

time42 minutes ago

  • Daily Record

NHS urges Tesco shoppers to read important life saving labels in store

The warning comes amid a new collaboration between the NHS and the supermarket giant on Tesco's own brand Luxury Soft toilet rolls. The NHS is encouraging Tesco shoppers to 'keep an eye out' and 'contact your GP practice if something doesn't feel right'. This health warning has been issued as Tesco's own brand-Luxury Soft toilet rolls now feature the NHS logo on the packaging. The collaboration between the NHS and the supermarket giant has been established to increase awareness surrounding bowel cancer among consumers. An NHS post on X, formerly known as Twitter, reads: "Keep an eye out for our logo on @Tesco toilet roll-78.9 million rolls sold and counting!" ‌ The initiative serves as a reminder for people to be aware of potential cancer symptoms when going to the bathroom. The NHS emphasises: "It's a reminder for people to look out for possible signs of cancer when going to the loo. Know what's normal for you and contact your GP practice if something doesn't feel right." ‌ Printed underneath the NHS logo on the toilet roll is the note: "Finding cancer earlier makes it more treatable and can save lives." Further details are provided on the back of the pack. The packaging also lists warning signs of cancer that may be visible during toilets visits like alterations in stool and the presence of blood. ‌ For more detailed information on cancer symptoms, the public is advised to visit the NHS website here. Symptoms of bowel cancer: changes in your stool, such as having softer stool, diarrhoea or constipation that is not usual for you needing to go to the toilet more or less often than usual for you blood in your stool, which may look red or black bleeding from your bottom often feeling like you need to empty your bowels, even if you've just been to the toilet tummy pain a lump in your tummy bloating losing weight without trying feeling very tired or short of breath – these are signs of anaemia, which can be caused by bowel cancer ‌ Many of these symptoms can be quite common and may also arise from various other health conditions. Experiencing these symptoms does not necessarily mean that you have cancer but it is essential you consult a GP for a check-up if you notice anything abnormal. If cancer is the cause behind your symptoms, early detection may make treatment more manageable. ‌ If anyone experiences symptoms of bowel cancer for three weeks or more, they should speak to a medical professional. The NHS reassures: "Try not to be embarrassed. The doctor or nurse will be used to talking about these symptoms. "If you notice your poo is black or dark red, or if you're experiencing bloody diarrhoea, it's crucial to seek an urgent GP appointment or get assistance from NHS 111. You can reach out by calling 111 or using the online help available at 111." ‌ Cancer can come in over 200 different forms and can affect any part of the body, including organs, blood, bone marrow, and the immune system. Sometimes, cancer can spread from its original site to other parts of the body, a process known as secondary cancer or metastasis. The type of cancer you have will determine the treatment you receive. ‌ Common cancer treatments include surgery to remove the tumour, chemotherapy with drugs that destroy cancer cells, and radiotherapy that uses radiation to target and kill cancer cells. Other treatment options might involve immunotherapy, which boosts your immune system to fight cancer, and hormone therapy, which aims to slow down or stop the growth of cancerous cells. The NHS assures patients: "You'll be looked after by a team of specialists who will work with you to create a treatment plan that is best for you."

Younger women could have cervical screening every five years instead of three
Younger women could have cervical screening every five years instead of three

North Wales Chronicle

timean hour ago

  • North Wales Chronicle

Younger women could have cervical screening every five years instead of three

The changes mean that, from next month, women aged 25 to 49 in England who are negative for human papillomavirus (HPV) will receive screening invites every five years. The move has been recommended by the UK National Screening Committee and is based on analysis from King's College London showing five-yearly screening is just as safe as three-yearly, with the same number of cancers found. HPV is a sexually-transmitted group of viruses which cause no symptoms. Around 13 high-risk types of HPV are known to cause 99.7% of all cervical cancers. As at present, any woman who has HPV or has a recent history of HPV will continue to be invited to more frequent screenings to check the virus has cleared and, if not, to check for cell changes in the cervix. In a written statement to Parliament, health minister Ashley Dalton said the new change 'increases the opportunities to test and recall women and people with a cervix who have HPV, while extending the cervical screening intervals from three to five years in England for individuals who have a negative HPV test. 'This will bring England's cervical screening intervals in line with those of Wales and Scotland.' She said the NHS screening programme in England provides all women between the ages of 25 and 64 'with the opportunity to be screened routinely to detect HPV infection or cervical abnormalities at an early, more treatable stage'. She added: 'The aim of the programme is to reduce the number of women who develop invasive cervical cancer and reduce the number who die from it.' Ms Dalton said testing negative for HPV means the chances of developing cancer within five years are very small, as it can take around 10 years or more from the time HPV is detected to developing cervical cancer. She added: 'Those who test positive for HPV are already being followed up with yearly testing. 'This is important to ensure that individuals are monitored for any early signs of cervical abnormalities and provided the necessary treatment.' Experts have been concerned about falling numbers of women under 50 attending cervical screening, with around a third in England not taking up their invitations. Dr Sue Mann, NHS national clinical director for women's health, said: 'Taking a more personalised approach to cervical screening will help ensure everyone eligible can make the most of these life-saving services, while sparing women appointments that they don't need. 'The NHS is following robust evidence on how often women need to be safely screened, and by putting invitations and reminders straight in women's pockets on their phones, we're making it easier than ever to take up screening appointments. 'Make sure you come forward for your screening when you're invited, even if it was weeks, months or years ago. If you think you are due but have not yet had an invitation, speak to your GP practice.' Michelle Mitchell, chief executive of Cancer Research UK, said: 'We welcome this change to cervical screening in England, which is the result of years of vital research to make screening more effective and has shown it is safe to extend the time between tests. 'Screening, alongside the roll out of the HPV vaccine – which Cancer Research UK scientists helped develop – have seen cervical cancer rates drop by around a quarter since the early 1990s, and we look forward to even more progress. 'If you notice any unusual changes for you, do not wait for a screening invitation – speak to your doctor.' Athena Lamnisos, chief executive of the Eve Appeal, said: 'We want every eligible person to feel empowered to attend a vaccination and cervical screening appointment when they are invited so we can achieve the brilliant ambition of eliminating cervical cancer.'

NHS updates cervical screening guidelines with millions of women affected
NHS updates cervical screening guidelines with millions of women affected

The Independent

timean hour ago

  • The Independent

NHS updates cervical screening guidelines with millions of women affected

Women aged 25 to 49 who test negative for human papillomavirus (HPV) will be invited to cervical screening every five years instead of every three, under new NHS guidelines. The change, set to take effect next month in England, follows recommendations from the UK National Screening Committee. According to analysis from King's College London, extending the screening interval to five years for HPV-negative women is just as safe as the current three-year interval, with a similar rate of cancer detection. HPV is a sexually transmitted group of viruses, with around 13 high-risk types known to cause almost all cases of cervical cancer. Most people with HPV don't experience any symptoms. Women who test positive for HPV, or have a history of the virus, will continue to be invited for more frequent screenings to monitor the virus and check for any changes to cells in the cervix. In a written statement to Parliament, health minister Ashley Dalton said the new change 'increases the opportunities to test and recall women and people with a cervix who have HPV, while extending the cervical screening intervals from three to five years in England for individuals who have a negative HPV test. 'This will bring England's cervical screening intervals in line with those of Wales and Scotland.' She said the NHS screening programme in England provides all women between the ages of 25 and 64 'with the opportunity to be screened routinely to detect HPV infection or cervical abnormalities at an early, more treatable stage'. She added: 'The aim of the programme is to reduce the number of women who develop invasive cervical cancer and reduce the number who die from it.' Ms Dalton said testing negative for HPV means the chances of developing cancer within five years are very small, as it can take around 10 years or more from the time HPV is detected to developing cervical cancer. She added: 'Those who test positive for HPV are already being followed up with yearly testing. 'This is important to ensure that individuals are monitored for any early signs of cervical abnormalities and provided the necessary treatment.' Experts have been concerned about falling numbers of women under 50 attending cervical screening, with around a third in England not taking up their invitations. Dr Sue Mann, NHS national clinical director for women's health, said: 'Taking a more personalised approach to cervical screening will help ensure everyone eligible can make the most of these life-saving services, while sparing women appointments that they don't need. 'The NHS is following robust evidence on how often women need to be safely screened, and by putting invitations and reminders straight in women's pockets on their phones, we're making it easier than ever to take up screening appointments. 'Make sure you come forward for your screening when you're invited, even if it was weeks, months or years ago. If you think you are due but have not yet had an invitation, speak to your GP practice.' Michelle Mitchell, chief executive of Cancer Research UK, said: 'We welcome this change to cervical screening in England, which is the result of years of vital research to make screening more effective and has shown it is safe to extend the time between tests. 'Screening, alongside the roll out of the HPV vaccine – which Cancer Research UK scientists helped develop – have seen cervical cancer rates drop by around a quarter since the early 1990s, and we look forward to even more progress. 'If you notice any unusual changes for you, do not wait for a screening invitation – speak to your doctor.' Athena Lamnisos, chief executive of the Eve Appeal, said: 'We want every eligible person to feel empowered to attend a vaccination and cervical screening appointment when they are invited so we can achieve the brilliant ambition of eliminating cervical cancer.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store